+

WO2003066820A3 - Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof - Google Patents

Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof Download PDF

Info

Publication number
WO2003066820A3
WO2003066820A3 PCT/US2003/003550 US0303550W WO03066820A3 WO 2003066820 A3 WO2003066820 A3 WO 2003066820A3 US 0303550 W US0303550 W US 0303550W WO 03066820 A3 WO03066820 A3 WO 03066820A3
Authority
WO
WIPO (PCT)
Prior art keywords
antigen
interest
methods
endosomal targeting
nucleic acid
Prior art date
Application number
PCT/US2003/003550
Other languages
French (fr)
Other versions
WO2003066820A2 (en
Inventor
Robert L Modlin
Original Assignee
Univ California
Robert L Modlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Robert L Modlin filed Critical Univ California
Priority to AU2003216184A priority Critical patent/AU2003216184A1/en
Publication of WO2003066820A2 publication Critical patent/WO2003066820A2/en
Publication of WO2003066820A3 publication Critical patent/WO2003066820A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides chimeric nucleic acid molecules encoding CD1 fusion proteins, comprising a leader peptide sequence, a CD1 endosomal targeting sequence, and an antigen of interest. In the CD1 fusion protein, the leader peptide sequence and CD1 endosomal targeting sequence direct production, processing, trafficking, and cell surface presentation of the antigen of interest via the MHCII antigen presenting pathway. The invention also provides methods for producing the CD1 fusion protein or the antigen of interest or fragments thereof, methods for targeting the antigen of interest to the MHCII antigen presenting pathway, and methods for presenting on a cell the antigen of interest. Additionally, the present invention provides methods for inducing in a subject an immune response mediated by a CD1 endosomal targeting sequence, methods for inducing in a subject an immune response to an antigen of interest, and methods for inducing in a subject an immune response mediated by an MHCII antigen presenting pathway.
PCT/US2003/003550 2002-02-05 2003-02-05 Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof WO2003066820A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003216184A AU2003216184A1 (en) 2002-02-05 2003-02-05 Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35543202P 2002-02-05 2002-02-05
US60/355,432 2002-02-05

Publications (2)

Publication Number Publication Date
WO2003066820A2 WO2003066820A2 (en) 2003-08-14
WO2003066820A3 true WO2003066820A3 (en) 2003-11-13

Family

ID=27734518

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/003550 WO2003066820A2 (en) 2002-02-05 2003-02-05 Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof

Country Status (2)

Country Link
AU (1) AU2003216184A1 (en)
WO (1) WO2003066820A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10347710B4 (en) * 2003-10-14 2006-03-30 Johannes-Gutenberg-Universität Mainz Recombinant vaccines and their use
US20070269457A1 (en) * 2006-05-16 2007-11-22 The Buck Institute For Age Research Immunotherapeutic compositions and methods
WO2010129537A1 (en) * 2009-05-05 2010-11-11 The Johns Hopkins University Phosphopeptides as melanoma vaccines
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
EP2603520A4 (en) 2010-08-10 2014-02-19 Ecole Polytech THERAPEUTIC AGENTS BINDING TO ERYTHROCYTES
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
EP3909603A1 (en) 2014-02-21 2021-11-17 Ecole Polytechnique Fédérale de Lausanne (EPFL) Glycotargeting therapeutics
US10370419B2 (en) 2014-12-09 2019-08-06 The Board Of Regents Of The University Of Textas System Tuberculosis vaccine compositions and related methods
WO2016191262A1 (en) * 2015-05-22 2016-12-01 The Regents Of The University Of California Methods and compositions related to antigen presenting proteins
WO2018232176A1 (en) 2017-06-16 2018-12-20 The University Of Chicago Compositions and methods for inducing immune tolerance
CN111868077A (en) * 2018-01-17 2020-10-30 南特生物公司 Enhanced immunogenicity of GPI-anchored antigens
EP4118210A4 (en) * 2020-03-11 2024-04-17 NantCell, Inc. TREATMENT OF COVID-19 AND METHODS THEREFOR
US11857620B2 (en) 2020-03-11 2024-01-02 Immunitybio, Inc. Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus
US20210284716A1 (en) * 2020-03-11 2021-09-16 Immunitybio, Inc. ACE2-Fc Trap
US12285480B2 (en) * 2020-03-11 2025-04-29 Nantcell, Inc. Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses
CN116554300B (en) * 2023-04-27 2023-10-24 湖北医药学院 A polypeptide capable of interacting with Clostridium difficile toxin TcdB and its application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020071842A1 (en) * 2000-06-05 2002-06-13 Gumperz Jenny E. Soluble CD1 compositions and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020071842A1 (en) * 2000-06-05 2002-06-13 Gumperz Jenny E. Soluble CD1 compositions and uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BILSLAND C.A.G. ET AL.: "The identification of the b2-microglobulin binding antigen encoded by the CD1D gene", EUR. J. IMMUNOL., vol. 21, 1991, pages 71 - 78, XP002965999 *
GEHO D.H. ET AL.: "Glycosyl-phosphatidylinositol reanchoring unmasks distinct antigen-presenting pathways for CD1b and CD1c", J. IMMUNOL., vol. 165, 2000, pages 1272 - 1277, XP002966000 *
SUGITA M. ET AL.: "Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs", SCIENCE, July 1996 (1996-07-01), pages 349 - 352, XP002965998 *
SUGITA M. ET AL.: "Pathways for lipid antigen presentation by CD1 molecules-nowhere for intracellular pathogens to hide", TRAFFIC, vol. 1, 2000, pages 295 - 300, XP002965997 *

Also Published As

Publication number Publication date
AU2003216184A8 (en) 2003-09-02
AU2003216184A1 (en) 2003-09-02
WO2003066820A2 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
WO2003066820A3 (en) Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof
EP3372617A3 (en) Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
WO2007130455A3 (en) Compositions and methods for treatment of non-hodgkins lymphoma
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
EP4450523A3 (en) Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
WO2005071088A3 (en) Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
WO2005067601A3 (en) Vectors for recombinant protein expression in e.coli
WO2005000235A3 (en) NUCLEIC ACID SEQUENCES ENCODING AND COMPOSITIONS COMPRISING IgE SIGNAL PEPTIDE AND/OR IL-15 AND METHODS FOR USING THE SAME
WO2002070652A3 (en) Novel molecules of the card-related protein family and uses thereof
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
WO2005028505A3 (en) Multiepitope polypeptides for cancer immunotherapy
ATE457352T1 (en) SUBTILISIN CARLSBERG PROTEINS WITH REDUCED IMMUNOGENICITY
WO2000052047A3 (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
WO2002044354A3 (en) Molecules of the card-related protein family and uses thereof
WO2003011331A3 (en) Materials and methods relating to improved vaccination strategies
WO2006047680A3 (en) Lactobacillus acidophilus nucleic acids and uses thereof
AU9336801A (en) Materials and methods relating to immune responses to fusion proteins
WO2002070657A3 (en) 93870, a human g-protein coupled receptor and uses therefor
WO2001092493A3 (en) 21956 and 25856, human aminopeptidases and uses thereof
WO2002055701A3 (en) Human sugar transporter proteins, potassium channel proteins, phospholipid transporter proteins and methods of use thereof
WO2004087886A3 (en) Modified adenoviral e1a constructs and methods of use thereof
WO2002000859A3 (en) 46508, a novel human peptidyl-trna hydrolase family member and uses thereof
WO2004047758A3 (en) Methods of therapy and diagnosis using targeting of cells that express p2y10
WO2001083752A3 (en) 23949 and 32391, human ion channels and uses thereof
WO2004053061A3 (en) Methods of therapy and diagnosis using targeting of cells that express lax

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载